Sushila R. Dalal to Adolescent
This is a "connection" page, showing publications Sushila R. Dalal has written about Adolescent.
Connection Strength
0.017
-
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
Score: 0.017